Author Question: Suppose that you hear about a chemistry department that did not give a promotion to a female faculty ... (Read 73 times)

gbarreiro

  • Hero Member
  • *****
  • Posts: 566
Suppose that you hear about a chemistry department that did not give a promotion to a female faculty member because of her gender. Based on the discussion at the beginning of Chapter 2, this kind of bias would be called
 
  a. discrimination.
  b. prejudice.
  c. stereotyping.
  d. benevolent sexism.

Question 2

Suppose that you know an individual who refused to hire a woman for a jobsimply on the basis of her gender. This would be an example of
 
  a. prejudice.
  b. a stereotype.
  c. discrimination.
  d. the social cognitive approach.



tdewitt

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

A

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library